| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 610.04M | 738.30M | 713.40M | 736.40M | 709.40M |
| Gross Profit | 284.34M | 338.00M | 284.30M | 298.90M | 289.00M |
| EBITDA | 107.00M | 27.20M | 115.60M | 23.70M | 87.30M |
| Net Income | -46.45M | -47.80M | 26.50M | -51.10M | 2.50M |
Balance Sheet | |||||
| Total Assets | 1.12B | 1.31B | 1.51B | 1.63B | 1.84B |
| Cash, Cash Equivalents and Short-Term Investments | 54.62M | 59.90M | 65.80M | 54.90M | 84.60M |
| Total Debt | 256.69M | 253.90M | 300.90M | 453.70M | 522.70M |
| Total Liabilities | 470.87M | 551.40M | 664.10M | 843.10M | 935.60M |
| Stockholders Equity | 644.13M | 757.00M | 847.30M | 783.90M | 901.00M |
Cash Flow | |||||
| Free Cash Flow | 54.01M | 62.20M | 38.60M | 29.90M | 13.60M |
| Operating Cash Flow | 76.78M | 100.00M | 76.80M | 77.00M | 66.70M |
| Investing Cash Flow | -8.47M | -37.50M | 101.10M | -46.90M | -65.00M |
| Financing Cash Flow | -84.23M | -59.80M | -168.00M | -57.80M | -25.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £548.38M | 22.53 | 6.22% | 9.48% | 0.58% | 61.58% | |
66 Neutral | £3.86B | 60.70 | 6.17% | 3.45% | 2.36% | -13.99% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £3.26B | -46.91 | -5.62% | 3.54% | -4.60% | -126.46% | |
60 Neutral | £124.27M | 32.05 | 8.02% | 4.08% | 1.12% | -0.70% | |
58 Neutral | £866.16M | -28.06 | 3.37% | 1.34% | -11.78% | -92.61% | |
51 Neutral | £29.34M | -1.25 | -7.26% | ― | -4.41% | 2.29% |
Elementis reported that across its various executive share option schemes, savings-related share option schemes and long term incentive plans, there were no new shares issued or allotted in the six months to 28 February 2026. The balances of unallotted securities in each scheme remained unchanged, while the company’s total shares in issue stood at 569,315,667 at the end of the period, indicating stable capital structure and no dilution for existing shareholders over this timeframe.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis reported resilient 2025 results in a weak demand environment, with revenue edging down 1% to $597.5m but adjusted operating profit rising 6.3% to $126.7m and margins improving to 21.2%. Personal Care was the standout, with revenue up 3.3% and operating margins jumping to 32.4%, while Coatings sales declined amid soft demand, though margins remained robust at 18.9%.
The group advanced its Elevate Elementis strategy by completing its transformation into a pure-play specialty chemicals business, delivering $18m of cost savings and boosting innovation-driven revenue to 16.4%. It bought natural skincare specialist Alchemy, agreed to sell its pharmaceutical manufacturing unit to ABF with proceeds earmarked for shareholders, completed a £40m buyback, and lifted the full-year dividend 7.5%, underscoring confidence despite ongoing macro and coatings-market headwinds.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £210.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis reported resilient 2025 results in a soft demand environment, with revenue slipping 1% to $597.5m but adjusted operating profit rising 4.6% at constant currency to $126.7m and margins improving to 21.2%. Personal Care led growth with revenues up 3.3% and a 32.4% margin, offsetting weaker Coatings demand, while net debt stood at $185.4m, leverage remained low at 1.3x EBITDA, and the dividend increased 7.5% alongside a completed £40m share buyback.
Strategically, the group completed the Talc disposal to become a pure-play specialty chemicals business, launched its Elevate Elementis growth plan, and agreed to sell its pharmaceutical manufacturing unit to Associated British Foods to sharpen its focus and enhance margins. Elementis also acquired Alchemy in fast-growing natural skincare, lifted capacity at its St. Louis site, delivered $18m of cost savings, and signalled it expects to return net cash proceeds from the pharma sale to shareholders while remaining cautiously optimistic amid ongoing weakness in coatings demand and geopolitical uncertainty.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £2.10 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc has confirmed that as of 28 February 2026 it has an issued and voting share capital of 569,315,667 ordinary shares of 5 pence each, of which 67,986 are held in treasury. This updated share count provides the official denominator for investors when calculating their holdings and determining whether they must disclose positions under the UK Financial Conduct Authority’s transparency rules, clarifying ownership thresholds for shareholders and the market.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £2.10 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc has announced a forthcoming change to its board, with independent non-executive director Dorothee Deuring set to retire on 28 February 2026. Her departure will also see her step down from the Audit, Nomination and Remuneration Committees after nine years of service, marking a planned refresh of the company’s governance structure and potentially opening room for new expertise on the board.
Chair John O’Higgins publicly thanked Deuring for her commitment and contribution over nearly a decade, underscoring the value of her role in board oversight. The move, made in line with UK listing requirements on director tenure and governance transparency, signals Elementis’s adherence to established corporate governance norms, which may reassure investors focused on board independence and regulatory compliance.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £2.10 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc reported that as of 31 January 2026 it has an issued and voting share capital of 569,303,958 ordinary shares of 5 pence each, of which 79,695 shares are held in treasury. The updated share count provides the official denominator for investors when calculating and disclosing their ownership stakes under UK transparency regulations, ensuring accurate reporting of significant shareholdings and maintaining compliance with market disclosure standards.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £2.10 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis reported a resilient 2025 trading performance, with revenue expected to be in line with market consensus and adjusted operating profit marginally ahead, supported by improved operating margins. Management attributed the margin gains to its Elevate Elementis strategy, operational simplification, ongoing cost savings and the bolt‑on acquisition of UK-based Alchemy Ingredients in November 2025, which together are intended to bolster efficiency and future growth. The group continues to generate positive free cash flow, leaving net debt (pre IFRS 16) at about $185m after a £40m share buyback, the sale of its disused Eaglescliffe site and associated environmental liabilities, and the Alchemy purchase, underscoring balance sheet strength and flexibility for future capital allocation. The board also noted that its chair succession process remains underway, with a further update to follow.
The most recent analyst rating on (GB:ELM) stock is a Buy with a £190.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc has reported that, as of 31 December 2025, its issued and voting share capital consists of 569,295,044 ordinary shares of 5 pence each, of which 88,609 are held in treasury. The disclosed figure will serve as the reference denominator for shareholders when calculating their holdings for regulatory disclosure purposes under the UK Financial Conduct Authority’s transparency rules, helping investors determine whether they must notify changes in their interests in the company.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc has confirmed a planned change in its senior leadership, with the appointment of Kath Kearney-Croft as Chief Financial Officer effective 1 January 2026 and the simultaneous departure of former CFO Ralph Hewins from both his role and the company’s Board. The transition, first announced in September 2025, signals continuity in the group’s financial stewardship, with the Board highlighting the orderly handover and expressing appreciation for Hewins’ role in ensuring a smooth changeover at the top of the finance function.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis PLC has disclosed a management share transaction involving its chief executive officer and director Luc Van Ravenstein. Following the maturity of 40,800 US savings-related share options granted in September 2023, Van Ravenstein has retained 37,174 Elementis shares at an option price of 94.86 pence per share, with the transaction executed on 23 December 2025 in London, underscoring continued equity alignment between senior management and shareholders.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis, a company engaged in a share buyback program, has repurchased 136,378 of its ordinary shares at an average price of 167.9346 pence per share. This transaction, conducted through Deutsche Bank AG, London Branch, is part of a strategic move to reduce the number of shares in circulation, potentially increasing the value for existing shareholders and adjusting the company’s capital structure.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis PLC has successfully completed its share buyback programme, purchasing over 24 million ordinary shares at a total cost of nearly £40 million. This move, which involved cancelling a significant portion of its issued share capital, is likely to impact the company’s financial structure and could influence its market positioning by enhancing shareholder value.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis, a company involved in a share buyback program, announced the purchase and cancellation of 165,000 of its own ordinary shares at an average price of 165.6504 pence per share. This transaction reduces the total number of ordinary shares in issue to 569,388,598, impacting the company’s voting rights and potentially affecting shareholder interests.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis, a company involved in the chemical industry, has executed a share buyback program as announced earlier this year. The company repurchased 165,000 of its ordinary shares at an average price of 165.5403 pence per share, which will be canceled, reducing the total number of shares in circulation. This move is part of Elementis’ strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding, thereby increasing earnings per share.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc, a company involved in a share buyback programme, has repurchased 165,000 of its ordinary shares at an average price of 165.8570 pence per share for cancellation. This transaction reduces the total number of ordinary shares in issue to 569,718,598, which may affect shareholder voting rights and interest calculations.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis, a company involved in a share buyback program, has repurchased 140,000 of its own ordinary shares at an average price of 166.4362 pence per share. This transaction, conducted through Deutsche Bank AG, London Branch, results in a total of 569,883,598 ordinary shares in issue, with the same number of voting rights available to shareholders. The buyback is part of a strategic move to manage the company’s capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.
Elementis plc, a company engaged in a share buyback programme, has announced the repurchase of 14,813 of its own ordinary shares at an average price of 166.1023 pence per share. This transaction is part of a previously announced buyback initiative aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. Following this purchase, the total number of shares in issue will be 570,023,598, with 131,433 shares held in treasury, impacting the voting rights and shareholding calculations for stakeholders.
The most recent analyst rating on (GB:ELM) stock is a Hold with a £178.00 price target. To see the full list of analyst forecasts on Elementis stock, see the GB:ELM Stock Forecast page.